Ameriprise’s Nuveen Dow 30SM Dynamic Overwrite Fund DIAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-89,655
Closed -$1.37M 4107
2025
Q4
$1.37M Sell
89,655
-11,447
-11% -$170K ﹤0.01% 3198
2025
Q3
$1.51M Buy
101,102
+510
+0.5% +$7.4K ﹤0.01% 3153
2025
Q2
$1.44M Buy
100,592
+13,573
+16% +$189K ﹤0.01% 3108
2025
Q1
$1.26M Buy
87,019
+9,523
+12% +$143K ﹤0.01% 3111
2024
Q4
$1.17M Buy
77,496
+20,537
+36% +$311K ﹤0.01% 3176
2024
Q3
$845K Sell
56,959
-11,967
-17% -$172K ﹤0.01% 3285
2024
Q2
$966K Sell
68,926
-29,476
-30% -$413K ﹤0.01% 3172
2024
Q1
$1.67M Sell
98,402
-28,012
-22% -$404K ﹤0.01% 2958
2023
Q4
$1.77M Sell
126,414
-41,728
-25% -$569K ﹤0.01% 2930
2023
Q3
$2.3M Buy
168,142
+12,099
+8% +$171K ﹤0.01% 2759
2023
Q2
$2.21M Sell
156,043
-19,722
-11% -$286K ﹤0.01% 2820
2023
Q1
$2.58M Buy
175,765
+54,700
+45% +$831K ﹤0.01% 2716
2022
Q4
$1.88M Buy
121,065
+4,539
+4% +$68.9K ﹤0.01% 2844
2022
Q3
$1.57M Sell
116,526
-2,233
-2% -$34.6K ﹤0.01% 2888
2022
Q2
$1.81M Buy
118,759
+18,805
+19% +$301K ﹤0.01% 2850
2022
Q1
$1.66M Buy
99,954
+8,220
+9% +$138K ﹤0.01% 2992
2021
Q4
$1.63M Sell
91,734
-4,975
-5% -$86.8K ﹤0.01% 3041
2021
Q3
$1.63M Buy
96,709
+3,522
+4% +$60.8K ﹤0.01% 2949
2021
Q2
$1.59M Buy
93,187
+15,086
+19% +$254K ﹤0.01% 3017
2021
Q1
$1.25M Buy
78,101
+21,807
+39% +$335K ﹤0.01% 3057
2020
Q4
$841K Sell
56,294
-10,667
-16% -$152K ﹤0.01% 3164
2020
Q3
$906K Sell
66,961
-1,035
-2% -$14.3K ﹤0.01% 3013
2020
Q2
$925K Sell
67,996
-16,402
-19% -$219K ﹤0.01% 2948
2020
Q1
$1.06M Buy
84,398
+17,603
+26% +$283K ﹤0.01% 2788
2019
Q4
$1.18M Buy
66,795
+9,572
+17% +$170K ﹤0.01% 2988
2019
Q3
$1.02M Sell
57,223
-17,711
-24% -$312K ﹤0.01% 3010
2019
Q2
$1.32M Buy
74,934
+22,363
+43% +$394K ﹤0.01% 2953
2019
Q1
$946K Buy
52,571
+12,972
+33% +$228K ﹤0.01% 3062
2018
Q4
$654K Sell
39,599
-6,398
-14% -$114K ﹤0.01% 3100
2018
Q3
$910K Sell
45,997
-9,510
-17% -$182K ﹤0.01% 3113
2018
Q2
$1.03M Buy
55,507
+5,353
+11% +$101K ﹤0.01% 3010
2018
Q1
$863K Sell
50,154
-45,690
-48% -$839K ﹤0.01% 3036
2017
Q4
$1.81M Sell
95,844
-26,823
-22% -$479K ﹤0.01% 2704
2017
Q3
$2.08M Sell
122,667
-23,093
-16% -$385K ﹤0.01% 2591
2017
Q2
$2.41M Sell
145,760
-15,948
-10% -$258K ﹤0.01% 2513
2017
Q1
$2.53M Buy
161,708
+40,892
+34% +$640K ﹤0.01% 2471
2016
Q4
$1.9M Buy
120,816
+42,278
+54% +$614K ﹤0.01% 2649
2016
Q3
$1.12M Buy
78,538
+32,825
+72% +$481K ﹤0.01% 2871
2016
Q2
$664K Sell
45,713
-3,740
-8% -$53K ﹤0.01% 3050
2016
Q1
$698K Buy
49,453
+31,827
+181% +$427K ﹤0.01% 3020
2015
Q4
$253K Buy
17,626
+1,691
+11% +$24.1K ﹤0.01% 3560
2015
Q3
$215K Buy
15,935
+191
+1% +$2.74K ﹤0.01% 3620
2015
Q2
$234K Buy
15,744
+5,520
+54% +$83.8K ﹤0.01% 3761
2015
Q1
$155K Buy
+10,224
New +$158K ﹤0.01% 3631

Other funds holding DIAX

Ameriprise's DIAX Position: Q1 2026 in Review

Ameriprise sold out of Nuveen Dow 30SM Dynamic Overwrite Fund (DIAX) in Q1 2026, closing a stake of 89,655 shares — an estimated $1.37M sold.

Ameriprise first reported a position in DIAX in Q1 2015 and held it in 44 quarters. The position peaked at $2.58M in Q1 2023. 3 funds tracked by Wall St. Rank hold DIAX as of Q1 2026.

  • Ameriprise reported no remaining Nuveen Dow 30SM Dynamic Overwrite Fund position as of Q1 2026 after selling out during the quarter.
  • Ameriprise sold 89,655 Nuveen Dow 30SM Dynamic Overwrite Fund shares in Q1 2026, an estimated $1.37M.
  • Ameriprise first reported a position in Nuveen Dow 30SM Dynamic Overwrite Fund in Q1 2015 and held it in 44 quarters.
  • Ameriprise's Nuveen Dow 30SM Dynamic Overwrite Fund position peaked at $2.58M in Q1 2023.
  • 3 funds tracked by Wall St. Rank held Nuveen Dow 30SM Dynamic Overwrite Fund as of Q1 2026.

Based on Ameriprise's 13F filing for Q1 2026, filed 15 May 2026.